Anti-ZEB1 antibody
Specifications
| Product Cat#: | AB-06-4694 |
| Product type: | Primary antibody |
| Antigen: | ZEB1 |
| Immunogen: | Purified recombinant fragment of human ZEB1 expressed in E. Coli |
| Species immunized: | Mouse |
| Isotype: | IgG1 |
| Applications: | Western Blot (1:500-1:1000); Immunohistochemistry (1:100-1:500); Flow Cytometry (1:100-1:200) |
| Reactivity: | Human |
| Clonality (clone number): | Monoclonal (A2-D8) |
| Form: | Liquid |
| Buffer: | Tris-HCl buffer (pH7.4), 1% BSA, 0.05% NaN3. |
| Concentration: | 1 mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | AREB 6 antibody |
| AREB6 antibody | |
| BZP antibody | |
| Delta crystallin enhancer binding factor 1 antibody | |
| DELTA EF1 antibody | |
| FECD6 antibody | |
| MGC133261 antibody | |
| Negative regulator of IL 2 antibody | |
| Negative regulator of IL2 antibody | |
| NIL 2 A antibody | |
| NIL 2 A zinc finger protein antibody | |
| NIL 2A antibody | |
| NIL-2-A zinc finger protein antibody | |
| NIL2A antibody | |
| Posterior polymorphous corneal dystrophy 3 antibody | |
| PPCD3 antibody | |
| Represses interleukin 2 expression antibody | |
| TCF 8 antibody | |
| TCF-8 antibody | |
| TCF8 antibody | |
| Transcription factor 8 (represses interleukin 2 expression) antibody | |
| Transcription factor 8 antibody | |
| ZEB 1 antibody | |
| ZEB antibody | |
| ZEB1 antibody | |
| ZEB1_HUMAN antibody | |
| ZFHEP antibody | |
| ZFHX 1A antibody | |
| ZFHX1A antibody | |
| Zinc finger E box binding homeobox 1 antibody | |
| Zinc finger E-box-binding homeobox 1 antibody | |
| Zinc finger homeodomain enhancer binding protein antibody |
Show More
Target information
Acts as a transcriptional repressor. Inhibits interleukin-2 (IL-2) gene expression. Enhances or represses the promoter activity of the ATP1A1 gene depending on the quantity of cDNA and on the cell type. Represses E-cadherin promoter and induces an epithelial-mesenchymal transition (EMT) by recruiting SMARCA4/BRG1. Represses BCL6 transcription in the presence of the corepressor CTBP1. Positively regulates neuronal differentiation. Represses RCOR1 transcription activation during neurogenesis. Represses transcription by binding to the E box (5′-CANNTG-3′). Promotes tumorigenicity by repressing stemness-inhibiting microRNAs.
Provider
Erpantech Laboratory
